Benjamin R. Yerxa - Mar 2, 2022 Form 3 Insider Report for Clearside Biomedical, Inc. (CLSD)

Role
Director
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
Stock symbol
CLSD
Transactions as of
Mar 2, 2022
Transactions value $
$0
Form type
3
Date filed
3/4/2022, 03:56 PM
Next filing
Jun 24, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CLSD Common Stock 10.1K Mar 2, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney